Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 5;56(10):1460–1474. doi: 10.1111/apt.17223

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 John Wiley & Sons Ltd.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

PMC Copyright notice

(A) Medications used to treat ulcerative colitis or IBD‐U flares in the pre‐pandemic and pandemic cohorts, following propensity score matching for age and physician global assessment of disease activity. (B) Proportion of patients with a Crohn's disease flare treated with different biologics and IMMs in the pre‐pandemic and pandemic cohorts, following propensity score matching for age and physician global assessment of disease activity. “n” numbers represent the total number of patients in each cohort. 5‐ASA, 5‐ aminosalicylate; IBD‐U, inflammatory bowel disease‐unspecified; IMM, immunomodulator; ns, not significant; TNF, tumour necrosis factor.